1. Home
  2. SILO vs STRR Comparison

SILO vs STRR Comparison

Compare SILO & STRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SILO
  • STRR
  • Stock Information
  • Founded
  • SILO 2010
  • STRR 1985
  • Country
  • SILO United States
  • STRR United States
  • Employees
  • SILO N/A
  • STRR N/A
  • Industry
  • SILO Apparel
  • STRR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • SILO Consumer Discretionary
  • STRR Health Care
  • Exchange
  • SILO Nasdaq
  • STRR Nasdaq
  • Market Cap
  • SILO 8.8M
  • STRR 7.0M
  • IPO Year
  • SILO N/A
  • STRR N/A
  • Fundamental
  • Price
  • SILO $1.54
  • STRR $2.09
  • Analyst Decision
  • SILO
  • STRR
  • Analyst Count
  • SILO 0
  • STRR 0
  • Target Price
  • SILO N/A
  • STRR N/A
  • AVG Volume (30 Days)
  • SILO 600.9K
  • STRR 8.5K
  • Earning Date
  • SILO 02-18-2025
  • STRR 03-21-2025
  • Dividend Yield
  • SILO N/A
  • STRR N/A
  • EPS Growth
  • SILO N/A
  • STRR N/A
  • EPS
  • SILO N/A
  • STRR N/A
  • Revenue
  • SILO $72,102.00
  • STRR $50,375,000.00
  • Revenue This Year
  • SILO $1.86
  • STRR $15.58
  • Revenue Next Year
  • SILO N/A
  • STRR $36.27
  • P/E Ratio
  • SILO N/A
  • STRR N/A
  • Revenue Growth
  • SILO N/A
  • STRR 2.22
  • 52 Week Low
  • SILO $0.77
  • STRR $2.05
  • 52 Week High
  • SILO $4.50
  • STRR $5.35
  • Technical
  • Relative Strength Index (RSI)
  • SILO 52.57
  • STRR 43.85
  • Support Level
  • SILO $1.56
  • STRR $2.05
  • Resistance Level
  • SILO $1.89
  • STRR $2.24
  • Average True Range (ATR)
  • SILO 0.19
  • STRR 0.07
  • MACD
  • SILO -0.05
  • STRR 0.01
  • Stochastic Oscillator
  • SILO 27.12
  • STRR 31.58

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

About STRR Star Equity Holdings Inc.

Star Equity Holdings Inc is a multi-industry diversified holding company with two segments: The construction segment manufactures modular housing units for commercial and residential applications. It operates in two businesses: modular building manufacturing and structural wall panel and wood foundation manufacturing, including building supply retail operations, and The investments segment holds corporate-owned real estate, which currently includes two manufacturing facilities in Maine that it leases back to KBS and manufacturing facility. The company derives maximum revenue from Construction Segment.

Share on Social Networks: